Biomedical Materials · asia
Keeping Surgical Fluorescence From Fading Quickly: Polymerized ICG Extends Near-Infrared Imaging
A Korean–U.S. team directly linked the clinically common dye indocyanine green into a polymer in an effort to slow photobleaching and prolong lymph node visualization. Cell and mouse results provide preliminary evidence, but comprehensive safety and pharmacokinetic hurdles remain before use in human surgery.
In image-guided surgery, fluorescence signals are more than bright spots on a screen; they may also affect the time window surgeons have to identify lymph nodes, blood vessels, and resection margins. However, indocyanine green (ICG), a near-infrared dye commonly used in clinical practice, readily fades rapidly under continuous illumination. A team from the Korea Research Institute of Chemical Technology and the Georgia Institute of Technology has now redesigned ICG through polymerization, hoping to make the signal last longer.
The new material is called KR-NIR-P. Rather than encapsulating the dye in another layer of nanocarrier or microcapsule, the researchers incorporated an ICG-derived chromophoric structure into a polymer backbone. This “carrier-free” design can immobilize the chromophores, reduce the proximity of oxygen molecules, and inhibit aggregation between dye molecules. All these factors are associated with irreversible decomposition and fluorescence decay after illumination.
Under continuous irradiation with a 785-nanometer laser, conventional ICG retained only about 40% of its initial fluorescence after 50 seconds, whereas KR-NIR-P still retained about 66% after 200 seconds. Based on this, the research team described its photostability as having improved by more than fourfold. However, the two figures were obtained at different irradiation time points. At this stage, it is more appropriate to interpret them as showing a clear improvement in the material’s ability to withstand continuous illumination, rather than as proof that surgical imaging time can be directly extended fourfold.
Preliminary biocompatibility tests showed that, at concentrations of up to 20 micromolar, KR-NIR-P maintained cell viability above 90% in both cancer cells and normal cells. Changes in apoptosis-related proteins were also not markedly greater than those observed with conventional ICG. In three-dimensional cell spheroids that simulate the structure of solid tumors, the material penetrated deeply and was distributed relatively evenly, indicating that it did not remain only on the surface of the tissue model.
The researchers also injected the material subcutaneously into the forepaws of mice. Fluorescence was observed in the sentinel lymph nodes two hours later, and the signal increased further after 24 hours. Sentinel lymph nodes are locations to which a tumor may first spread through the lymphatic system, so this result supports the material’s potential as a dye for lymphatic localization. However, whether the long-term accumulation of the signal reflects desirable retention, slower clearance, or both still needs to be clarified with pharmacokinetic data.
The study remains at the stages of cells, three-dimensional tissue models, and mice and has not yet entered human testing. Favorable cell viability cannot replace assessments of systemic toxicity, immune responses, metabolites, organ distribution, and elimination pathways. Polymerization may also alter ICG’s original behavior in the body. The team’s next step will be to expand toxicology and pharmacokinetic studies. Only after manufacturing consistency, dosage, and clinical imaging benefits have all been confirmed could KR-NIR-P progress from a photostable material to the operating room.